Health profiles of 996 melanoma survivors: the M. D. Anderson experience
نویسندگان
چکیده
منابع مشابه
Liposarcoma of the head and neck: The University of Texas M. D. Anderson Cancer Center experience.
BACKGROUND Our aim was to review our experience with liposarcoma of the head and neck region. METHODS This is a retrospective case series at a comprehensive cancer center (1945-2005). RESULTS Of 30 patients, 10 (33%) were initially misdiagnosed. Local recurrences were common (overall rate = 53%), and 4 patients (13%) developed distant metastases. Decreased crude disease-specific survival ra...
متن کاملAdult ependymal tumors: prognosis and the M. D. Anderson Cancer Center experience.
Ependymomas in adults are rare and often misdiagnosed. This study reports on a series of adult patients with confirmed ependymoma treated at The University of Texas M. D. Anderson Cancer Center (MDACC). Patients aged >17 and with ependymoma were identified, and clinical data were collected by retrospective chart review. Descriptive statistics were used to describe the clinical data, Kaplan-Meie...
متن کاملanalysis of reading comprehension needs of the students of paramedical studies: the case of the students of health information management (him)
چکیده ندارد.
15 صفحه اولLow-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experience.
BACKGROUND Recombinant interleukin (IL)-11 is a thrombopoietic growth factor. The purpose of this study was to assess the toxicity, safety and efficacy of low-dose recombinant IL-11 in patients with bone marrow failure (BMF). PATIENTS AND METHODS Patients with BMF due to myelodysplastic syndromes (MDS), graft failure, chemotherapy or aplastic anemia (AA) were treated. Patients were required t...
متن کاملPrognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M. D. Anderson Cancer Center experience.
BACKGROUND T-cell non-Hodgkin lymphomas (T-NHL) are more aggressive and patients have a poorer prognosis compared with patients with the corresponding B-cell lymphomas. Although intensive treatments have been developed, it is unknown whether they are more effective than CHOP chemotherapy (cyclophosphamide, doxorubicin, oncovorin, and prednisone). METHODS The authors' retrospective study evalu...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMC Cancer
سال: 2006
ISSN: 1471-2407
DOI: 10.1186/1471-2407-6-95